New

North America Virology Market

2021

North America Virology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Diagnostic Test, Viral Infection Controlling Techniques, Antiviral Therapeutics, and Interferons), Application (Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Sexually Transmitted Diseases, Urinary Tract Infection, and Others), and End User (Hospitals, Diagnostic Laboratories, Pharmaceutical and Biotechnological Companies, and Research and Academic Institutes)

Publication Month: Nov 2021 | Report Code: TIPRE00025739 | No. of Pages: 178 | Category: Biotechnology | Status: Published

Market Insights

North America Virology Market to Grow at a CAGR of 3.8% to reach US$ 1,984.33 million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The virology market in North America is expected to grow from US$ 1,531.21 million in 2021 to US$ 1,984.33 million by 2028; it is estimated to grow at a CAGR of 3.8% from 2021 to 2028.

The US, Canada, and Mexico are economies in North America. Viral infection is among the leading causes of human chronic diseases. A few viruses, such as human immunodeficiency virus (HIV), flu virus, Zika, Diphtheria, Ebola, SARS-CoV-2 (COVID-19), Polio, and Tetanus (Lockjaw), infect large populations across the world. As virus mutate and evolve continuously, drug resistance become an impending challenge for viral infection management among the human and animals. A virus transmits through various mediums based on its type. For instance, some viruses cause respiratory viral diseases, such as flu, common cold, and respiratory syncytial virus infection, transmits through droplets generated through coughing or sneezing, while some because gastrointestinal viral diseases transmitted through feces contaminated food or water. The novel coronavirus that causes COVID-19 was identified in 2019. The International Committee on Taxonomy of Viruses (ICTV) declared the virus as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) on February 11, 2020, and later WHO named the disease as COVID-19. The virus has undergone mutation a couple of times since its outbreak, which has added to the severity of the COVID-19 pandemic. Therefore, the rising prevalence of viral infections drives the growth of the North America virology market.

North America has experienced a rising number of cases of COVID-19 since its outbreak. The cases are also increasing in countries such as Mexico and Canada in the region. As COVID19 is a novel virus and had no established treatment methods, no vaccines, drugs specific to the virus were not available. Thus, it was a potential opportunity for product innovation and development to the market players operating in the virology-related business. The governments have extensively invested in and promoted vaccine development and prioritized the easy and quick approval process. Regional and international players launch various virus products such as rapid test kits, vaccines, and others. And the large-scale production of these products and rising demand are expected to have a favorable impact on the virology-related market in the region. However, the end-users' panic buying and stocking of the products are expected to cause a loss in terms of product expiry. Thus, such factors are expected to have a negative impact on the related market in the region.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive virology market. The North America virology market is expected to grow at a good CAGR during the forecast period.
North America virology market

Get more information on this report :


North America Virology Market Segmentation

North America Virology Market – By Type

  • Diagnostic Test
    • DNA Virus Testing
    • RNA Virus Testing
    • Others
  • Viral Infection Controlling Techniques
    • Active Prophylaxis
    • Passive Prophylaxis
  • Antiviral Therapeutics
    • Virucidal Agents
    • Antiviral Agents
    • Immunomodulators
  • Interferons

North America Virology Market – By Application

  • Skin and Soft Tissue Infections
  • Respiratory Tract Infections
  • GI Tract Infections
  • Sexually Transmitted Diseases
  • Urinary Tract Infections
  • Others

North America Virology Market – By End User

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical and Biotechnological Companies
  • Research and Academic Institutes

North America Virology Market- By Country

  • US
  • Canada
  • Mexico

North America Virology Market-Companies Mentioned

  • Abbott
  • AbbVie Inc.
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline Plc
  • Illumina, Inc.
  • Johnson and Johnson Services, Inc.
  • QIAGEN
  • Siemens AG
  • Thermo fisher scientific inc.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Virology Market – By Type

1.3.2 North America Virology Market – By Application

1.3.3 North America Virology Market – By End User

1.3.4 North America Virology Market– By Country

2. North America Virology Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Virology Market– Market Landscape

4.1 Overview

4.2 North America PEST Analysis

4.3 Experts Opinion

5. North America Virology Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rise in Prevalence of Viral Infectious Diseases

5.1.2 Increasing Product Launches

5.2 Market Restraints

5.2.1 Availability of Alternative Products and High Cost of Production of Products

5.3 Market Opportunities

5.3.1 Tremendous Growth Potential in Several Economies

5.4 Future Trends

5.4.1 Continuous Requirement for Cost-Effective Products

5.5 Impact Analysis

6. Virology Market– North America Analysis

6.1 North America Virology Market Revenue Forecast and Analysis

7. North America Virology Market Analysis – By Type

7.1 Overview

7.2 North America Virology Market Revenue Share, by Type (2021 and 2028)

7.3 Diagnostic Test

7.3.1 Overview

7.3.2 Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Deoxyribonucleic Acid (DNA) Virus Testing

7.3.2.1.1 Overview

7.3.2.1.2 DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 Ribonucleic Acid (RNA) Virus Testing

7.3.2.2.1 Overview

7.3.2.2.2 RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.3 Others

7.3.2.3.1 Overview

7.3.2.3.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Viral Infection Controlling Techniques

7.4.1 Overview

7.4.2 Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.1 Active Prophylaxis

7.4.2.1.1 Overview

7.4.2.1.2 Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.2 Passive Prophylaxis

7.4.2.2.1 Overview

7.4.2.2.2 Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Antiviral Therapeutics

7.5.1 Overview

7.5.2 Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.1 Virucidal Agents

7.5.2.1.1 Overview

7.5.2.1.2 Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.2 Antiviral Agents

7.5.2.2.1 Overview

7.5.2.2.2 Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.3 Immunomodulators

7.5.2.3.1 Overview

7.5.2.3.2 Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Interferons

7.6.1 Overview

7.6.2 Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8. North America Virology Market Analysis – By Application

8.1 Overview

8.2 North America Virology Market, by Application 2021 & 2028 (%)

8.3 Skin and Soft Tissue Infections

8.3.1 Overview

8.3.2 Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Respiratory Tract Infections

8.4.1 Overview

8.4.2 Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.5 GI Tract Infections

8.5.1 Overview

8.5.2 GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Sexually Transmitted Diseases

8.6.1 Overview

8.6.2 Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Urinary Tract Infections

8.7.1 Overview

8.7.2 Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Virology Market Analysis – By End User

9.1 Overview

9.2 North America Virology Market Revenue Share, by End User (2021 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Diagnostic Laboratories

9.4.1 Overview

9.4.2 Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Pharmaceutical and Biotechnological Companies

9.5.1 Overview

9.5.2 Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Research and Academic Institutes

9.6.1 Overview

9.6.2 Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Virology Market – Country Analysis

10.1.1 Overview

10.1.2 North America: Virology Market, by Country, 2021 & 2028 (%)

10.1.2.1 US: Virology Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 Overview

10.1.2.1.2 US: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3 US: Virology Market, by Type, 2019–2028 (USD Million)

10.1.2.1.3.1 US: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.1.3.2 US: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.1.3.3 US: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.1.4 US: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.1.5 US: Virology Market, by End User, 2019–2028 (USD Million)

10.1.2.2 Canada: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 Overview

10.1.2.2.2 Canada: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3 Canada: Virology Market, by Type, 2019–2028 (USD Million)

10.1.2.2.3.1 Canada: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.2.3.2 Canada: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.2.3.3 Canada: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.2.4 Canada: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.2.5 Canada: Virology Market, by End User, 2019–2028 (USD Million)

10.1.2.3 Mexico: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 Overview

10.1.2.3.2 Mexico: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3 Mexico: Virology Market, by Type, 2019–2028 (USD Million)

10.1.2.3.3.1 Mexico: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.3.3.2 Mexico: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.3.3.3 Mexico: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.3.4 Mexico: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.3.5 Mexico: Virology Market, by End User, 2019–2028 (USD Million)

11. Impact of COVID-19 Pandemic on North America Virology Market

11.1 Overview

12. North America Virology Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Johnson and Johnson Services, Inc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 F. HOFFMANN-LA ROCHE LTD.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 THERMO FISHER SCIENTIFIC INC.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 QIAGEN

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Illumina, Inc.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Siemens AG

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 GlaxoSmithKline Plc

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 AbbVie Inc.

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Gilead Sciences, Inc.

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Virology Market Revenue and Forecast to 2028 (US$ Million)

Table 2. US: Virology Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 3. US: Virology Market, by Diagnostic Test – Revenue and Forecast to 2028 (USD Million)

Table 4. US: Virology Market, by Viral Infection Controlling Techniques – Revenue and Forecast to 2028 (USD Million)

Table 5. US: Virology Market, by Antiviral Therapeutics – Revenue and Forecast to 2028 (USD Million)

Table 6. US: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 7. US Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 8. Canada: Virology Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 9. Canada: Virology Market, by Diagnostic Test – Revenue and Forecast to 2028 (USD Million)

Table 10. Canada: Virology Market, by Viral Infection Controlling Techniques – Revenue and Forecast to 2028 (USD Million)

Table 11. Canada: Virology Market, by Antiviral Therapeutics – Revenue and Forecast to 2028 (USD Million)

Table 12. Canada: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 13. Canada: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 14. Mexico: Virology Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 15. Mexico: Virology Market, by Diagnostic Test – Revenue and Forecast to 2028 (USD Million)

Table 16. Mexico: Virology Market, by Viral Infection Controlling Techniques – Revenue and Forecast to 2028 (USD Million)

Table 17. Mexico: Virology Market, by Antiviral Therapeutics – Revenue and Forecast to 2028 (USD Million)

Table 18. Mexico: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 19. Mexico: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 20. Organic Developments Done by Companies

Table 21. Inorganic Developments Done by Companies

Table 22. Glossary of Terms, North America Virology Market

LIST OF FIGURES

Figure 1. North America Virology Market Segmentation

Figure 2. North America Virology Segmentation, By Country

Figure 3. North America Virology Market Overview

Figure 4. Antiviral Therapeutics Held the Largest Share of the Type Segment in North America Virology Market

Figure 5. Respiratory Tract Infections Held the Largest Share of the Application Segment in North America Virology Market

Figure 6. US to Show Significant Growth During Forecast Period

Figure 7. North America PEST Analysis

Figure 8. North America Virology Market: Impact Analysis of Drivers and Restraints

Figure 9. North America Virology Market– Revenue Forecast and Analysis – 2019- 2028

Figure 10. North America Virology Market Revenue Share, by Type (2021 and 2028)

Figure 11. North America Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. North America DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. North America RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. North America Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. North America Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. North America Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. North America Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. North America Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. North America Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. North America Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. North America Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. North America Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. North America Virology Market, by Application 2021 & 2028 (%)

Figure 24. North America Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. North America Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. North America GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. North America Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. North America Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. North America Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. North America Virology Market Revenue Share, by End User (2021 and 2028)

Figure 31. North America Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. North America Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. North America Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. North America Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. North America: Virology Market, by Key Country – Revenue (2021) (USD Million)

Figure 36. North America: Virology Market, by Country, 2021 & 2028 (%)

Figure 37. US: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 38. Canada: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 39. Mexico: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 40. Impact of COVID-19 Pandemic in North American Country Markets

  1. Abbott
  2. AbbVie Inc.
  3. F. Hoffmann-La Roche Ltd.
  4. Gilead Sciences, Inc.
  5. GlaxoSmithKline Plc
  6. Illumina, Inc.
  7. Johnson and Johnson Services, Inc.
  8. QIAGEN
  9. Siemens AG
  10. Thermo Fisher Scientific Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America Virology market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America Virology market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the Virology market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
TIPRE00025739
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.